Experienced in Juvenile Temporal Arteritis

Julie Seguier

CHU Marseille
Marseille, FR 
Experienced in Juvenile Temporal Arteritis
CHU Marseille
Marseille, FR 
OverviewLocationsClinical Research

Overview

Julie Seguier practices in Marseille, France. Ms. Seguier is rated as an Experienced expert by MediFind in the treatment of Juvenile Temporal Arteritis. Her top areas of expertise are Hereditary Hemorrhagic Telangiectasia, Telangiectasia, Takayasu Arteritis, and Idiopathic Neutropenia.

Her clinical research consists of co-authoring 36 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles in the study of Juvenile Temporal Arteritis.

Gender
Female

Locations

CHU Marseille
Marseille, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Efficacy of Nintedanib Per os as a Treatment for Epistaxis in HHT Disease. A National, Randomized, Multicentre Phase II Study
Efficacy of Nintedanib Per os as a Treatment for Epistaxis in HHT Disease. A National, Randomized, Multicentre Phase II Study
Enrollment Status: Completed
Publish Date: August 01, 2025
Intervention Type: Drug
Study Drug: Nintedanib
Study Phase: Phase 2
Multicentre Randomized Double-blind Placebo-controlled Study to Evaluate the Effect on Albuminuria of 6 Months Treatment With Hydroxycarbamide (Siklos®) or a Placebo in Adults With Sickle Cell Disease:
Multicentre Randomized Double-blind Placebo-controlled Study to Evaluate the Effect on Albuminuria of 6 Months Treatment With Hydroxycarbamide (Siklos®) or a Placebo in Adults With Sickle Cell Disease:
Enrollment Status: Completed
Publish Date: May 14, 2025
Intervention Type: Drug
Study Drug: Hydroxycarbamide
Study Phase: Phase 2
View 1 Less Clinical Trial

36 Total Publications

Effectiveness of intravenous infliximab versus subcutaneous adalimumab in Takayasu arteritis: multicenter retrospective study.
Effectiveness of intravenous infliximab versus subcutaneous adalimumab in Takayasu arteritis: multicenter retrospective study.
Journal: Rheumatology (Oxford, England)
Published: October 28, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Seguier's expertise for a condition
ConditionClose
      View All 41 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile